Predictive Oncology partners with Cvergenx to create new genomics-based AI radiation therapy
New York --News Direct-- Predictive Oncology Inc.
Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence (AI).
Vennare said the objective of this collaboration will be to leverage Predictive Oncology’s drug discovery, AI and machine learning capabilities with the Cvergenx precision genomics radiation therapy platform.
Contact Details
Proactive US
+1 347-449-0879
na-editorial@proactiveinvestors.com
View source version on newsdirect.com: https://newsdirect.com/news/predictive-oncology-partners-with-cvergenx-to-create-new-genomics-based-ai-radiation-therapy-151675745
